Results 141 to 150 of about 163,785 (367)

Levels of Galectin-3, Advanced Glycated End-Products in Serum, Endothelial Function and Cardiac Hemodynamics in Post Infarction Heart Failure in Patients with Reduced and Preserved Ejection Fraction [PDF]

open access: yes, 2018
Epidemiological studies have reported that the rate of signs and symptoms of heart failure after myocardial infarction is approximately 25%. In addition, approximately 40% of myocardial infarctions are accompanied by left ventricular systolic ...
Kuryata, O., Sirenko, O., Zabida, A.
core  

Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction [PDF]

open access: yes, 2018
Aims: The mechanisms of exercise intolerance in heart failure with preserved ejection fraction (HFpEF) are not yet elucidated. Chronotropic incompetence has emerged as a potential mechanism.
Bellver, Alejandro   +9 more
core   +1 more source

Promising Prodiginins Biological Activities

open access: yesChemistry &Biodiversity, EarlyView.
ABSTRACT Prodiginins are a large family of at least 34 pyrrolic compounds, including the well‐studied red pigment prodigiosin. Prodiginins are produced by several microorganisms displaying broad biological activities, including antimicrobial, antiviral, antiparasitic, antiproliferative, and immunosuppressive activities.
María F. Ladetto   +6 more
wiley   +1 more source

Cardiovascular diseases and comorbidity in patients with chronic heart failure and preserved ejection fraction depending on age [PDF]

open access: yes, 2017
The aim of the study was to determine the cardiovascular dis) eases and comorbidity in patients with chronic heart failure and preserved ejection fraction depending on age.
Dobrohorska, H.O.   +2 more
core  

New Classification for Heart Failure with Mildly Reduced Ejection Fraction : Greater clarity or more confusion? [PDF]

open access: yes, 2017
The latest European Society of Cardiology (ESC) guidelines for the diagnosis and management of heart failure include a new patient group for those with heart failure with mildly reduced ejection fraction (HFmrEF).
Nadar, Sunil
core   +3 more sources

Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Vasoplegic syndrome (VS) is a common complication after cardiac surgery with cardiopulmonary bypass (CPB). The main pathophysiology mechanism of VS includes a systemic inflammatory response syndrome due to surgical trauma, release of pro‐inflammatory mediators caused by blood contact with foreign surfaces of heart‐lung machine (pump and tubing)
Matteo Lucchelli   +3 more
wiley   +1 more source

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis

open access: yesBrazilian Journal of Medical and Biological Research
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome in which patients have symptoms and signs of HF with normal or near-normal left ventricular ejection fraction (LVEF ≥50%).
Chao Ma   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy